@daicosisgod, This acquisition is material in my opinion, and it will add A$60-80M in revenue/yr and possibly A$40M/year in direct contribution. This has been achieved under MYX leadership and cash and therefore the Independent must conclude that whatever the first offer was, ($7.4/share), the valuation must now be much higher.
More news from the Australian today
https://www.theaustralian.com.au/business/pharmaceutical-giant-mayne-upbeat-for-2025-despite-the-spectre-of-trump-tariffs/news-story/bda7b4487282cbe0e7316c815726b8a0?amp
I'll be Voting NO
Ann: Business update, new licensing and updated scheme timetable, page-11
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.09 |
Change
-0.110(2.12%) |
Mkt cap ! $422.4M | |||
| Open | High | Low | Value | Volume |
| $5.19 | $5.19 | $5.09 | $68.49K | 13.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1767 | $5.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.09 | 50 | 1 |
View Market Depth
| Last trade - 10.06am 16/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |